The pharmacological activities of δ9-THC [(−)-δ9-trans-tetrahydrocannabinol], CBN (Cannabinol) and mixtures of δ9-THC + CBN were studied in rabbits, rats and mice.
CBN, although in general less active, mimicked the effects of δ9-THC in several pharmacological tests: corneal arreflexia in rabbits; climbing rope, open-field, irritability and aggressiveness after REM sleep deprivation in rats; catatonia, analgesia and sleeping time in mice.
When the mixture δ9-THC + CBN was used, a synergistic effect occurred on most of the depressant effects. On the other hand CBN did not interfere with or slightly inhibited the excitatory effects of δ9-THC. In the one peripheral test used, CBN did not alter the δ9-THC effect.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Alves, C. N., Goyos, A. C., Carlini, E. A.: Aggressiveness induced by marihuana and other psychotropic drugs in REM sleep deprived rats. Pharmacol. Biochem. Behav. 1, 183–189 (1973)
Borgen, L. A., Lott, G. C., Davis, W. M.: Cannabis induced hypothermia: a dose effect comparison of crude marihuana extract and synthetic δ9-tetrahydrocannabinol in male and female rats. Res. Com. Chem. Path. Pharmacol. 5, 621–627 (1973)
Carlini, E. A., Masur, J.: Development of aggressive behavior in rats by chronic administration of Cannabis sativa (marihuana). Life Sci. 8 (part 1), 607–620 (1969)
Carlini, E. A., Masur, J., Karniol, I. G., Leite, J. R.: II. Cannabis sativa: Is it possible to consider behavioral animal data as experimental models for some effects on humans? In: Cannabis and its derivatives, pharmacology and experimental psychology. Paton, W. D. M. and Crown, J., eds., pp. 154–175. London: Oxford University Press 1972
Carlini, E. A., Karniol, I. G., Renault, P. F., Schuster, C. R.: Marihuana effects in laboratory animals and in human beings. Brit. J. Pharmacol. 50, 299–310 (1974)
Eddy, N. B., Leimbach, D.: Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines. J. Pharmacol. exp. Ther. 107, 385–393 (1953)
Fernandes, M., Coper, H.: The role of vehicles in cannabis application and interaction between cannabis and central active drugs. Acta pharm. suecica 8, 692–693 (1971)
Frankenheim, J. M., McMillan, D. E., Harris, L. S.: Effects of δ9- and δ8-trans-tetrahydrocannabinol and cannabinol on schedule-controlled behavior of pigeons and rats. J. Pharmacol. exp. Ther. 178, 241–253 (1971)
Grisham, M. G., Ferraro, D. P.: Biphasic effects of δ9-tetrahydrocannabinol on variable interval schedule performance in rats. Psychopharmacologia (Berl.) 27, 163–170 (1972)
Hollister, L. E.: Marihuana in man: three years later. Science 172, 21–28 (1971)
Karniol, I. G., Carlini, E. A.: The content of (−) δ9-transtetrahydrocannabinol does not explain all biological activity of some brazilian marihuana samples. J. Pharm. Pharmacol. 24, 833–835 (1972)
Karniol, I. G., Carlini, E. A.: Pharmacological interaction between cannabidiol and δ9-tetrahydrocannabinol. Psychopharmacologia (Berl.) 33, 53–70 (1973)
Karniol, I. G., Shirakawa, I., Kasinski, N., Pfefferman, A., Carlini, E. A.: Cannabidiol interferes with the effects of δ9-tetrahydrocannabinol in man. Europ. J. Pharmacol., submitted to publication
Krantz, J. C., Berger, H. J., Welch, B. L.: Blockade of (−)-trans-δ9-tetrahydrocannabinol depressant effect by cannabinol in mice. Amer. J. Pharmacol. 143, 149–152 (1971)
Lapa, A. J., Sampaio, C. A. M., Timo-Iaria, C., Valle, J. R.: Blocking action of tetrahydrocannabinol upon transmission in the trigeminal system of the cat. J. Pharm. Pharmacol. 20, 373–376 (1968)
Loewe, S.: Marihuana activity of cannabinol. Science 102, 615–616 (1945)
Masur, J.: Sex differences in “emotionality” and behavior of rats in the open-field. Behav. Biol. 7, 749–754 (1972)
Masur, J., Martz, R. M. W., Carlini, E. A.: Effects of acute and chronic administration of Cannabis sativa and (−)-δ9-trans-tetrahydrocannabinol on the behavior of rats in an open-field arena. Psychopharmacologia (Berl.) 19, 388–397 (1971)
Mechoulam, R., Ben-Zvi, Z., Shani, A., Zemler, H., Levy, S., Edery, H., Grunfeld, Y.: Cannabinoids and Cannabis activity. In: Cannabis and its derivatives-pharmacology and experimental psychology, Paton, W. D. M., and Crown, J., eds., pp. 1–15. London: Oxford University Press 1972
Nakamura, K., Thoenen, H.: Increased irritability: a permanent behavior change induced in the rat by the intraventricular administration of 6-hydroxytryptamine. Psychopharmacologia (Berl.) 24, 359–372 (1972)
Poddar, M. K., Ghosh, J. J.: Effect of cannabis extract, δ9-tetrahydrocannabinol and lysergic acid diethylamide on rat liver enzymes. Biochem. Pharmacol. 21, 3301–3303 (1972)
Potvin, R. J., Fried, P. A.: Acute and chronic effects on rats of (−)-δ1-trans-tetrahydrocannabinol on unlearned motor tasks. Psychopharmacologia (Berl.) 26, 369–378 (1972)
Sofia, R. D., Kubena, R. K., Barry, H., III: Comparison of four vehicles for intraperitoneal administration of δ1-tetrahydrocannabinol. J. Pharm. Pharmacol. 23, 889–891 (1971)
Willinsky, M. D., Scotti, A. C., Longo, V. G.: EEG and behavioral effects of natural synthetic and biosynthetic cannabinoids. Psychopharmacologia (Berl.) 31, 365–374 (1973)
With a fellowship from FundaÇÃo de Amparo a Pesquisa do Estado de S. Paulo.
About this article
Cite this article
Takahashi, R.N., Karniol, I.G. Pharmacological interaction between cannabinol and δ9-tetrahydrocannabinol. Psychopharmacologia 41, 277–284 (1975). https://doi.org/10.1007/BF00428937
- Cannabinoid Compounds
- Pharmacological Interaction